Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |